IL1B and colitis: Similarly, the injection of IGNVs loaded with curcumin (IGNVs-Cur), a known anti-inflammatory agent [68], increased the survival rate of mice with DSS-induced colitis and decreased TNF-α, IL-6, and IL-1β levels in colonic tissue compared with free Cur and GNVs-Cur [69].